Replies to post #38037 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Yes after 10 full years on the job they have 5 generic drugs FDA approved...3 of which cost them 10's of millions of dollars to get FDA approved and didn't translate to a shred of value being added to IPCI's valuation metrics because all 3 were never partnered or commercialized! Furthermore this woefully inept and incompetent mgmt. team still decided to pay themselves FAT bonuses on those 3 approvals even though not a single shred of value was provided in return for the 10's of millions of dollars worth of dilution it took to get those 3 drugs approved just to sit on a shelf and collect dust!

And their remaining 2 approved generics are generating a combined paltry yearly revenue of $2M while this company is now diluting $15M per annum!

Do the math on that alone!

They're diluting $15M per year now and not growing their paltry $2M per annum revs at all.

So if you really think 10 years into the dream this company is a supposed success story with 2 commercialized generics on the market generating them a paltry $2M per year combined measured against the $15M per year they're still diluting so be it.

But from my vantage point this company spent 100's of millions of dollars of dilutive funding over the course of the past decade and hasn't even remotely delivered any relevant value in return...hence the reason its trading at historic lows with the FUD factors still plaguing this stock reigning supreme despite this company pumping out news non-stop these days as they desperately try to mask and ignore all their woeful incompetence and inefficiencies exhibited over the past 5 years especially!

[cjstocksup]

Also I have read for days from non shareholders that Andrew Patient left. No he is still here! IPCI got 4 new filings yesterday plus the 6K news and Andrew Patient signed them all. Still acting CFO as far as all the filings. Good news to me.

[mopar44o]

5 drugs equalling near nothing in revenue but costing shareholders huge in bonuses